Site Members can sign up for company wide alerts
Lawsuit Overview
June 23, 2014 (Shareholders Foundation) - An investor, who currently holds shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX) filed a lawsuit in effort to halt the takeover of Idenix Pharmaceuticals Inc . by Merck for $24.50 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:IDIX stockholders by agreeing to sell Idenix Pharmaceuticals...
You must register (for free) or login to view the entire case.